SNCE News and Press, Science 37 Holdings Inc. From 08/08/23

2023-08-08 06:20:00 ET Science 37 press release ( NASDAQ: SNCE ): Q2 GAAP EPS of -$0.17 misses by $0.02 . Adjusted net loss was $7.7 million for the quarter ended June 30, 2023 Revenue of $15.35M (-20.5% Y/Y) beats by $2.78M . Full Year 2023 Fin...

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended June 30, 2023. “The actions we have taken ove...

RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial results prior to the market open on Tuesday, August 8, 2023. The Science 37 management...

RESEARCH TRIANGLE PARK, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ has been chosen by Synlogic, (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel oral, non-systemically absorbed bio...

RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best Overall Clinical Trial Platform" award in the 7th annual MedTech Breakthrough Awards...

2023-05-15 12:35:25 ET Science 37 Holdings, Inc. (SNCE) Q1 2023 Earnings Call May 15, 2023 8:30 AM ET Company Participants Steve Halper - LifeSci Advisors David Coman - Chief Executive Officer Mike Zaranek - Chief Financial Officer Conference Call Participa...

2023-05-15 06:07:26 ET Science 37 press release ( NASDAQ: SNCE ): Q1 GAAP EPS of -$0.21 misses by $0.03 . Revenue of $14.1M (-24.6% Y/Y) beats by $1.22M . Net bookings were $11.7 million for the quarter ended March 31, 2023, compared to $30.6 million for t...

RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended March 31, 2023. “First quarter results reflect...

RESEARCH TRIANGLE PARK, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite TM , today announced its partnership with the Digital Medicine Society (DiMe) in support of the CancerX inaugural project. Answering the call of the White Hou...

RESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial results prior to the market open on Monday, May 15, 2023. The Science 37 management team...